Chinese expert consensus on transcatheter tricuspid valve intervention therapy
10.3969/j.issn.1004-8812.2024.10.002
- VernacularTitle:三尖瓣反流经导管治疗的中国专家共识
- Author:
Chinese College of Cardiovascular Physicians Structural Cardiology Group
;
House Heart CHINA
;
Wen-Zhi PAN
;
Guang-Yuan SONG
;
Da-Xin ZHOU
;
Yong-Jian WU
- Keywords:
Tricuspid regurgitation;
Transcatheter tricuspid valve intervention;
Expert consensus
- From:
Chinese Journal of Interventional Cardiology
2024;32(10):551-561
- CountryChina
- Language:Chinese
-
Abstract:
Tricuspid regurgitation(TR)is a common heart valve disease traditionally treated with surgery,which is invasive and high-risk.Recently,transcatheter tricuspid valve intervention(TTVI)technology has achieved major breakthroughs.It is being promoted internationally and several expert consensus documents have been launched abroad.However,in China,there is still a lack of consensus documents in this regard.In order to promote the safe,standardized and healthy development of this technology,this expert consensus is specially compiled.This consensus will introduce anatomy,epidemiology,classification and pathogenesis of TR,the traditional treatment and TTVI,preoperative evaluation and clinical efficacy endpoints.We sort out ten core viewpoints so that readers can quickly grasp the essence of the consensus.
